Nano Labs Announces Results of Annual General Meeting of Shareholders
Nano Labs (Nasdaq: NA) announced the results of its Annual General Meeting held on October 23, 2024. Shareholders approved three key resolutions: (1) A share consolidation of 10:1, changing share par value from $0.0002 to $0.002, resulting in an authorized capital of $50,000 divided into 25 million ordinary shares; (2) Adoption of new memorandum and articles of association reflecting the share consolidation; and (3) Appointment of MaloneBailey, LLP as independent auditor for FY2024. The share consolidation will take effect on October 29, 2024.
Nano Labs (Nasdaq: NA) ha annunciato i risultati della sua Assemblea Generale Annuale tenutasi il 23 ottobre 2024. Gli azionisti hanno approvato tre risoluzioni chiave: (1) Una consolidazione delle azioni di 10:1, che modifica il valore nominale delle azioni da $0.0002 a $0.002, portando a un capitale autorizzato di $50.000 suddiviso in 25 milioni di azioni ordinarie; (2) Adozione di un nuovo memorandum e statuto che riflettono la consolidazione delle azioni; e (3) Nomina di MaloneBailey, LLP come revisore indipendente per l'anno fiscale 2024. La consolidazione delle azioni entrerà in vigore il 29 ottobre 2024.
Nano Labs (Nasdaq: NA) anunció los resultados de su Junta General Anual celebrada el 23 de octubre de 2024. Los accionistas aprobaron tres resoluciones clave: (1) Una consolidación de acciones de 10:1, cambiando el valor nominal de las acciones de $0.0002 a $0.002, resultando en un capital autorizado de $50,000 dividido en 25 millones de acciones ordinarias; (2) Aprobación de un nuevo memorando y estatutos que reflejan la consolidación de acciones; y (3) Designación de MaloneBailey, LLP como auditor independiente para el año fiscal 2024. La consolidación de acciones entrará en vigor el 29 de octubre de 2024.
나노랩스 (Nasdaq: NA)가 2024년 10월 23일에 열린 연례 총회 결과를 발표했습니다. 주주들은 세 가지 주요 결의를 승인했습니다: (1) 주식의 통합 비율을 10:1로 하여 주식의 액면가를 $0.0002에서 $0.002로 변경하며, 이를 통해 25백만 주의 보통주로 나누어진 $50,000의 허가된 자본을 구성합니다; (2) 주식 통합을 반영하는 새로운 각서 및 정관의 채택; (3) FY2024를 위한 독립 감사인으로 말론베일리, LLP의 임명. 주식 통합은 2024년 10월 29일부터 시행됩니다.
Nano Labs (Nasdaq: NA) a annoncé les résultats de sa Assemblée Générale Annuelle qui s'est tenue le 23 octobre 2024. Les actionnaires ont approuvé trois résolutions clés : (1) Une consolidation des actions de 10:1, changeant la valeur nominale des actions de $0.0002 à $0.002, ce qui entraîne un capital autorisé de $50,000 divisé en 25 millions d'actions ordinaires; (2) Adoption d'un nouveau mémorandum et d'articles d'association reflétant la consolidation des actions; et (3) Nommer MaloneBailey, LLP comme auditeur indépendant pour l'exercice 2024. La consolidation des actions prendra effet le 29 octobre 2024.
Nano Labs (Nasdaq: NA) gab die Ergebnisse seiner Hauptversammlung bekannt, die am 23. Oktober 2024 stattfand. Die Aktionäre genehmigten drei wesentliche Beschlüsse: (1) Eine Aktienzusammenlegung von 10:1, die den Nennwert der Aktien von $0.0002 auf $0.002 ändert und in der Folge ein genehmigtes Kapital von $50.000 in 25 Millionen Stammaktien ergibt; (2) Annahme eines neuen Memorandum und Statuten, die die Aktienzusammenlegung widerspiegeln; und (3) Ernennung von MaloneBailey, LLP als unabhängigen Prüfer für das Geschäftsjahr 2024. Die Aktienzusammenlegung tritt am 29. Oktober 2024 in Kraft.
- None.
- 10:1 share consolidation may indicate attempt to maintain Nasdaq listing requirements
- Share consolidation could potentially reduce stock liquidity
Insights
The approved 10:1 share consolidation for Nano Labs is a significant corporate action that will reduce the number of outstanding shares while proportionally increasing the share price. This move could potentially enhance stock marketability and reduce volatility, though it doesn't fundamentally change the company's market value. The consolidation might help meet Nasdaq's minimum bid price requirements and attract institutional investors who often avoid low-priced stocks.
The appointment of MaloneBailey, LLP as the independent auditor and the adoption of new articles of association are standard corporate governance measures. The share restructuring, which includes specific allocations for Class A and Class B shares, indicates a strategic approach to maintaining control structure while adapting to market conditions.
HANGZHOU, China, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, today announced the results of the Company’s Annual General Meeting (“AGM”) held at 10 A.M. on October 23, 2024, Beijing time (10 P.M., October 22, 2024, U.S. Eastern time). The proposals submitted for shareholder approval at the AGM have been approved. Specifically, the shareholders have passed the following resolutions:
(1) to effect a share consolidation of every ten shares with a par value of US
(2) to amend the Company’s memorandum and articles of association currently in effect by the adoption of a new memorandum and articles of association to reflect the Share Consolidation (after the amendment, the “New M&A”); and
(3) to approve the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
The Share Consolidation will be effective from 5 P.M. on October 29, 2024, Eastern time.
About Nano Labs Ltd
Nano Labs Ltd is a leading fabless integrated circuit (“IC”) design company and product solution provider in China. Nano Labs is committed to the development of high throughput computing (“HTC”) chips, high performance computing (“HPC”) chips, distributed computing and storage solutions, smart network interface cards (“NICs”) vision computing chips and distributed rendering. Nano Labs has built a comprehensive flow processing unit (“FPU”) architecture which offers solution that integrates the features of both HTC and HPC. Nano Lab's Cuckoo series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company’s website at: ir.nano.cn.
* According to an industry report prepared by Frost & Sullivan.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s plan to appeal the Staff’s determination, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
For investor inquiries, please contact:
Nano Labs Ltd
ir@nano.cn
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
FAQ
When will Nano Labs (NA) share consolidation take effect?
What is the new share structure for Nano Labs (NA) after consolidation?